Assignee
METABASIS THERAPEUTICS INC
US·51 granted patents·10 pending applications·2,162 citations·filing 1995–2019
Top patents by PatentIndex Score
61 records- 0198US6489476B1Heteroaromatic compounds containing a phosphonate group that are inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1999·Granted Dec 3, 2002·231 cites·165 claims
- 0298US6312662B1Prodrugs phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 1999·Granted Nov 6, 2001·384 cites·183 claims
- 0397US6752981B1Prodrugs for liver specific drug deliveryMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 22, 2004·105 cites·92 claims
- 0497US6399782B1Benzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jun 4, 2002·136 cites·37 claims
- 0596US6110903ABenzimidazole inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Aug 29, 2000·132 cites·52 claims
- 0696US6054587AIndole and azaindole inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Apr 25, 2000·147 cites·47 claims
- 0795US6946115B2Prodrugs for phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 2001·Granted Sep 20, 2005·51 cites·18 claims
- 0895US6294672B1Indole and azaindole inhibitors of Fructose-1,6-biphosphataseMETABASIS THERAPEUTICS INC·Filed 2000·Granted Sep 25, 2001·52 cites·22 claims
- 0995US6284748B1Purine inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 1998·Granted Sep 4, 2001·137 cites·39 claims
- 1094US7514419B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 7, 2009·25 cites·18 claims
- 1194US6965033B2Bisamidate phosphonate prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Nov 15, 2005·57 cites·55 claims
- 1291US7351399B2Prodrugs for phosphorus-containing compoundsMETABASIS THERAPEUTICS INC·Filed 2005·Granted Apr 1, 2008·8 cites·9 claims
- 1390US7582758B2Lewis acid mediated synthesis of cyclic estersMETABASIS THERAPEUTICS INC·Filed 2005·Granted Sep 1, 2009·18 cites·39 claims
- 1490US7553826B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·11 cites·29 claims
- 1589US7666855B22′-C-methyl nucleoside derivativesMETABASIS THERAPEUTICS INC·Filed 2006·Granted Feb 23, 2010·12 cites·37 claims
- 1689US5763597AOrally active adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·125 cites·28 claims
- 1789US5763596AC-4' modified adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Jun 9, 1998·117 cites·32 claims
- 1888US7816345B2Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2007·Granted Oct 19, 2010·8 cites·55 claims
- 1988US6967193B1Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Nov 22, 2005·27 cites·6 claims
- 2088US6919322B2Phenyl Phosphonate Fructose-1,6-Bisphosphatase InhibitorsMETABASIS THERAPEUTICS INC·Filed 2001·Granted Jul 19, 2005·28 cites·56 claims
- 2188US6680379B1Organic anion transporter genes and proteinsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Jan 20, 2004·14 cites·20 claims
- 2287US7829552B2Phosphorus-containing thyromimeticsMETABASIS THERAPEUTICS INC·Filed 2004·Granted Nov 9, 2010·24 cites·16 claims
- 2387US5795977AWater soluble adenosine kinase inhibitorsMETABASIS THERAPEUTICS INC·Filed 1996·Granted Aug 18, 1998·106 cites·21 claims
- 2486US9701626B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2015·Granted Jul 11, 2017·5 cites·10 claims
- 2586US9169201B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 27, 2015·8 cites·13 claims
- 2685US10034891B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2016·Granted Jul 31, 2018·2 cites·4 claims
- 2785US7205404B1Phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2000·Granted Apr 17, 2007·17 cites·61 claims
- 2885US7151092B2Cytarabine monophosphate prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 19, 2006·13 cites·11 claims
- 2984US10925885B2Thyromimetics for the treatment of fatty liver diseasesMETABASIS THERAPEUTICS INC·Filed 2018·Granted Feb 23, 2021·4 cites·25 claims
- 3083US7498320B2Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Granted Mar 3, 2009·5 cites·64 claims
- 3182US9340566B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2015·Granted May 17, 2016·2 cites·10 claims
- 3282US7303739B2Prodrugs for liver specific drug deliveryMETABASIS THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·14 cites·88 claims
- 3382US6756360B1Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetesMETABASIS THERAPEUTICS INC·Filed 1999·Granted Jun 29, 2004·48 cites·74 claims
- 3481US7381736B2Thiazole and thiadiazole inhibitors of tyrosine phosphatasesMETABASIS THERAPEUTICS INC·Filed 2005·Granted Jun 3, 2008·7 cites·19 claims
- 3580US10239829B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 26, 2019·2 cites·20 claims
- 3680US7371739B2Aryl fructose-1,6-bisphosphatase inhibitorsMETABASIS THERAPEUTICS INC·Filed 2005·Granted May 13, 2008·4 cites·79 claims
- 3779US9783494B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2014·Granted Oct 10, 2017·3 cites·21 claims
- 3879US7312219B2Heteroaromatic inhibitors of fructose 1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 25, 2007·10 cites·145 claims
- 3979US7214668B2Phosphonic acid based prodrugs of PMEA and its analoguesMETABASIS THERAPEUTICS INC·Filed 2003·Granted May 8, 2007·16 cites·30 claims
- 4078US7193081B2Process for preparation of cyclic prodrugs of PMEA and PMPAMETABASIS THERAPEUTICS INC·Filed 2003·Granted Mar 20, 2007·13 cites·66 claims
- 4177US7285543B2Purine inhibitors of fructose-1,6-bisphosphataseMETABASIS THERAPEUTICS INC·Filed 2005·Granted Oct 23, 2007·2 cites·6 claims
- 4276US10709718B2Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereofMETABASIS THERAPEUTICS INC·Filed 2018·Granted Jul 14, 2020·1 cites·11 claims
- 4376US7148349B2Cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugsMETABASIS THERAPEUTICS INC·Filed 2003·Granted Dec 12, 2006·7 cites·80 claims
- 4475US10221130B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2017·Granted Mar 5, 2019·1 cites·14 claims
- 4573US11352321B2Glucagon antagonistsMETABASIS THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·0 cites·15 claims
- 4669US2008004226A1Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of DiabetesMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4768US10807946B2Antagonists of the glucagon receptorMETABASIS THERAPEUTICS INC·Filed 2019·Granted Oct 20, 2020·0 cites·10 claims
- 4862US2008015195A1Novel Heteroaromatic Inhibitors of Fructose-1,6-BisphosphataseMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 4961US2007249564A1Novel phosphorus-containing prodrugsMETABASIS THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 5061US2007232571A1Novel Heteroaromatic Inhibitors of Fructose-1,6-BisphosphataseMETABASIS THERAPEUTICS INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when METABASIS THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →